规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | CYP4A11/CYP4F2-IN-2 acts as a potent, orally available inhibitor that targets both cytochrome P450 4A11 and CYP4F2 enzymes, displaying IC50 values of 140 nM and 40 nM, respectively. This dual inhibitor holds promise for studies related to kidney diseases[1]. |
Animal study | Administered orally in a single dose ranging from 0.03 to 1 mg/kg, CYP4A11/CYP4F2-IN-2 proportionally decreases the production of 20-HETE in the kidneys of rats[1].When given intravenously at 0.5 mg/kg to mice, CYP4A11/CYP4F2-IN-2 shows a low clearance rate (1430 mL/h/kg), a moderate volume of distribution at steady state (763 mL/kg), and a short half-life (0.424 hours)[1].At a dosage of 1 mg/kg administered intravenously to Sprague-Dawley (SD) rats, the inhibitor demonstrates a low clearance rate (226 mL/h/kg), a moderate volume of distribution at steady state (839 mL/kg), and a half-life of approximately 3.01 hours[1].Following oral administration at 1 mg/kg to SD rats, CYP4A11/CYP4F2-IN-2 reaches a maximum concentration (Cmax) of 623 ng/mL, has a half-life of 3.03 hours, and exhibits high bioavailability (97.7%)[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.33mL 0.67mL 0.33mL |
16.65mL 3.33mL 1.66mL |
33.29mL 6.66mL 3.33mL |
CAS号 | 2126874-77-7 |
分子式 | C16H20N4O2 |
分子量 | 300.36 |
SMILES Code | CC(N1CCC(COC2=CC=C(C3=NNC=C3)N=C2)CC1)=O |
MDL No. | N/A |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|